COMMUNIQUÉS West-GlobeNewswire

Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea
13/03/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against Gonorrhoea Oxford, UK, and Cambridge, MA, US, 13 March [...]
Sunesis Pharmaceuticals Announces Cancellation of Presentation and Webcast at Cowen & Company 38th Annual Health Care Conference
13/03/2018
Cancellation due to Travel Changes Caused by Inclement Weather Management to Proceed with Scheduled Investor Meetings via Conference Calls SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Sunesis [...]
Tonix Pharmaceuticals to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), announced today that it will present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering [...]
Melinta Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
Baxdela ™ (delafloxacin) Launched February 6, 2018, in U.S. for Adults with ABSSSI Acquired Infectious Disease Business from The Medicines Company on January 5, 2018 First Earnings Report as a Public Company NEW HAVEN, [...]
Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call
13/03/2018
Heidelberg, Germany, March 13, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that on March [...]
PotNetwork Holding To Enter World’s Fastest Growing Market With Formation Of Blockchain Crypto Technology Subsidiary
13/03/2018
FT LAUDERDALE, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding Inc. (OTC Pink:POTN) (“Company”), announced today that after considerable evaluation and planning, the Company enters into [...]
Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration
13/03/2018
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem [...]
United Health Products Receives CE Mark Approval for HemoStyp®
13/03/2018
Henderson, Nev., March 13, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]
Final transactions in relation to share buyback program
13/03/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Ossur Hf : Share buy-back of 1,478,700 own shares
13/03/2018
Announcement no. 21/2018 Reykjavik, 13 March 2018 Share buy-back of 1,478,700 own shares Today, Össur purchased 1,478,700 own shares at the price of DKK 28.10 per share. The total purchase price amounted to DKK 41.55 [...]
PCI Biotech: Invitation to full year 2017 presentation
13/03/2018
Oslo, 13 March 2018 - PCI Biotech invites to a presentation of the company's full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday March 20, 08:30am - 09:30am CET (local [...]
Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration
13/03/2018
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem [...]
UPDATE -- Immuron Commences US Non-Deal Institutional Investor Roadshow
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC)(NASDQ:IMRN) is pleased to release to shareholders and investors its latest Company [...]
Kiadis Pharma N. V.: Kiadis Pharma raises €23.4 million in a private placement of 2.6 million new shares
13/03/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION [...]
Gallup and Sharecare Announce Annual Community Rankings
13/03/2018
ATLANTA, March 13, 2018 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, and world-leading analytics and advice firm, Gallup , today reported their [...]
MediciNova to Participate in Business Development Panel Session at the BIO Asia International Conference in Tokyo
13/03/2018
LA JOLLA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]
Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced the appointment of Narinder Singh as [...]
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
12/03/2018
Single dose of vaccine showed 67% survival rate and 100% survival rate after two doses GAITHERSBURG, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, [...]
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017
12/03/2018
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 Conference call and webcast on Tuesday, March 13 th at 1:30 pm CET/8:30 am EDT Reported positive data from Phase 2b clinical trial of [...]

Pages